High Performance Optics, “HPO” of Roanoke, Virginia, www.HPOusa.com a company focused on human retinal protection from blue light, announced today that it has exclusively licensed Essilor www.Essilor.com globally with its technology, intellectual property, trade secrets, and know how regarding the selective blue light filtering of spectacle lenses.
Essilor and HPO have independently developed “selective” blue light filtering spectacle lens technology capable of protecting the retina of the human eye from the hazards of high energy blue light. The companies believe the HPO global exclusive license to Essilor will allow for a more rapid exploitation and adoption of the technology globally and in addition speed its availability to the global population. Both companies have agreed to share the technology with the optical / vision care industry worldwide by way of global sublicensing.
Mike Packard , President of HPO stated. “I am most pleased and excited about having HPO team up with Essilor to exploit this highly beneficial technology globally. While there are multiple factors that contribute to AMD, reducing the chances of others suffering from Macula Degeneration and / or the severity of this ugly eye disease has been a key goal of HPO’s for the past many years. This is most gratifying to me personally.”
HPO has been researching the harmful effects of blue light on the human retina since 2000 and has amassed a very extensive intellectual property portfolio with numerous patent applications pending and multiple patents that have issued around the world.